| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $233.0K | $202.0K | $1.5M |
| YoY Revenue Growth % | +15.3% | -86.2% | — |
| Gross Profit | -$321.0K | -$576.0K | — |
| Gross Margin % | -50.0% | -50.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$31.7M | -$35.8M | -$87.8M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$34.0M | -$35.5M | -$87.1M |
| EBITDA (Normalized) | -$31.6M | -$35.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$27.8M | -$26.6M | -$50.7M |
| Capital Expenditures (CapEx) | $109.0K | $486.0K | — |
| Free Cash Flow (FCF) | -$27.9M | -$27.1M | -$50.7M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $43.4M | $10.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $81.3M | $15.1M | — |